1,541
Views
11
CrossRef citations to date
0
Altmetric
Review

Ocular Symptoms of SARS-CoV-2: Indication of Possible Ocular Transmission or Viral Shedding

, OD, MPhil, PhD, FAAOORCID Icon, , OD, PhDORCID Icon, , OD, MScORCID Icon, , OD, MMed, PhDORCID Icon, , OD, MPhil, PhDORCID Icon, , OD, PhD & , MSc, PhDORCID Icon show all
Pages 1269-1279 | Received 25 May 2020, Accepted 17 Jul 2020, Published online: 01 Sep 2020

References

  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7.
  • Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401, 402.
  • The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, China. SSRN Electron J. 2020;2(8): 113–122.
  • Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;1–5. Internet. doi:10.1080/09273948.2020.1738501.
  • Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
  • Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–269. doi:10.1038/s41586-020-2008-3.
  • Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. 2020; figure 2. 1–4.
  • Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–582. doi:10.7326/M20-0504.
  • van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–1567. doi:10.1056/NEJMc2004973.
  • Tang A, Tong ZD, Wang HL, et al. Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China. Emerg Infect Dis. 2020;26:6. doi:10.3201/eid2606.200301.
  • Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–971. doi:10.1056/NEJMc2001468.
  • Green A. Li Wenliang. Lancet. 2020;395(10225):682. doi:10.1016/S0140-6736(20)30382-2.
  • Lu C, Liu X, Jia Z. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395(10224):e39. doi:10.1016/S0140-6736(20)30313-5.
  • Liu L, Sun Y, Pan X, Shen W, Liu ZY, Liu YP. Expression of SARS coronavirus S proteinfunctional receptor-angiotensin-converting enzyme 2 in human cornea and conjunctiva. Chin Ophthal Res. 2004;22:561–564.
  • Loon SC, Teoh SCB, Oon LLE, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004;88(7):861–863. doi:10.1136/bjo.2003.035931.
  • Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–423. doi:10.1002/jmv.25681.
  • Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. doi:10.1016/S0140-6736(20)30251-8.
  • Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94:7. doi:10.1128/JVI.00127-20.
  • Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol A J Pathol Soc Gt Britain Irel. 2004;203:631–637.
  • Holappa M, Vapaatalo H, Vaajanen A. Many faces of renin-angiotensin system - focus on eye. Open Ophthalmol J. 2017;11(1):122–142. doi:10.2174/1874364101711010122.
  • Belser JA, Rota PA, Tumpey TM. Ocular tropism of respiratory viruses. Microbiol Mol Biol Rev. 2013;77(1):144–156. doi:10.1128/MMBR.00058-12.
  • Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature [Internet]. 2020 May 28;581(7809):465–469. doi:10.1038/s41586-020-2196-x.
  • Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10):929–936. doi:10.1056/NEJMoa2001191.
  • General Office of National Health Commission. General office of national administration of traditional Chinese medicine. Diagnostic and Treatment Protocol for Novel Coronavirus Pneumonia Trial version 7, revised form. 2020.
  • Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19 [Internet]. Vol. 20, The Lancet infectious diseases. Lancet Publishing Group; 2020. doi:10.1016/S1473-3099(20)30232-2.
  • Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. Jama. 2020;323(14):1406. doi:10.1001/jama.2020.2565.
  • Kimball A, Hatfield KM, Arons M, et al. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility—King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69(13):377.
  • Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa2001316.
  • Mission, WHO-China Joint. Report of the Who-china Joint Mission on Coronavirus Disease 2019 (Covid-19). Geneva; 2020.
  • Ong SWX, Tan YK, Chia PY, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. Jama. 2020;323(16):1610. doi:10.1001/jama.2020.3227.
  • Paulsen F. Functional anatomy and immunological interactions of ocular surface and adnexa. In: Geerling G, Brewitt H, eds. Surgery for the Dry Eye. Dev Ophthalmol. Vol. 41. Basel: Karger Publishers; 2008:21–35.
  • Leclerc QJ, Fuller NM, Knight LE, Funk S, Knight GM, What settings have been linked to SARS-CoV-2 transmission clusters? Wellcome Open Res Internet]. 2020 Jun 5;5:83. doi: 10.12688/wellcomeopenres.15889.2.
  • Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19): X A case report. Can J Ophthalmol Can D’ophtalmologie [Internet]. 2020;1–6. doi:10.1016/j.jcjo.2020.03.003.
  • Zhang X, Chen X, Chen L, et al. The infection evidence of SARS-COV-2 in ocular surface: a single-center cross-sectional study. 2020. 8197033356.
  • Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;2019:4–7.
  • Santarpia JL, Rivera DN, Herrera V, et al. Transmission potential of SARS-CoV-2 in viral shedding observed at the university of nebraska medical center. medRxiv. 2020. https://doi.org/10.1101/2020.03.23.20039446. Accessed April 4, 2020.
  • Yu SI, Jun ADE, Eng A, et al. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology [Internet]. 2020;2019. https://doi.org/10.1016/j.ophtha.2020.03.026
  • Zhou Y, Zeng Y, Tong Y, Chen C 2020 Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. 2.
  • Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection. J Med Virol. 2020;92(6):589–594. doi:10.1002/jmv.25725.
  • van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med. 2004;10(4):368–373. doi:10.1038/nm1024.
  • Chin MS, Hooper LC, Hooks JJ, Detrick B. Identification of α-fodrin as an autoantigen in experimental coronavirus retinopathy (ECOR). J Neuroimmunol. 2014;272(1–2):42–50. doi:10.1016/j.jneuroim.2014.05.002.
  • Wang Y, Detrick B, Yu Z-X, Zhang J, Chesky L, Hooks JJ. The role of apoptosis within the retina of coronavirus-infected mice. Invest Ophthalmol Vis Sci. 2000;41:3011–3018.
  • Vinores SA, Wang Y, Vinores MA, et al. Blood–retinal barrier breakdown in experimental coronavirus retinopathy: association with viral antigen, inflammation, and VEGF in sensitive and resistant strains. J Neuroimmunol. 2001;119(2):175–182. doi:10.1016/S0165-5728(01)00374-5.
  • Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-7.
  • Raboud J, Shigayeva A, McGeer A, et al. Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS One. 2010;5:5. doi:10.1371/journal.pone.0010717.
  • Drosten C, Chiu -L-L, Panning M, et al. Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol. 2004;42(5):2043–2047. doi:10.1128/JCM.42.5.2043-2047.2004.
  • Lang J, Yang N, Deng J, et al. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS One. 2011;6:8. doi:10.1371/journal.pone.0023710.
  • Zhao J, Yang Y, Huang H, et al. Relationship between the ABO Blood Group and the COVID-19 susceptibility. medRxiv. 2020. https://doi.org/10.1101/2020.03.11.20031096.
  • Sun C, Wang Y, Liu G, Liu Z. Role of the eye in transmitting human coronavirus: what we know and what we do not know. 2020.
  • Stalin Raj VS, Mou H, Smits S, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nat Int Wkly J Sci. 2013;495(7440):251–254.
  • Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454. doi:10.1038/nature02145.
  • Kaiser J. How sick will the coronavirus make you? The answer may be in your genes. Science. 2020;368. https://www.sciencemag.org/news/2020/03/how-sick-will-coronavirus-make-you-answer-may-be-your-genes. Accessed March 20, 2020.
  • Sun Y, Liu L, Pan X, Jing M. Mechanism of the action between the SARS-CoV S240 protein and the ACE2 receptor in eyes. Int J Ophthalmol Chi. 2006;6:783.
  • Bialek S, Boundy E, Bowen V, COVID CDC, Team R. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343–346. doi:10.15585/mmwr.mm6912e2.
  • Lai THT, Tang EWH, Chau SKY, Fung KSC, Li KKW. Stepping up infection control measures in ophthalmology during the novelcoronavirus outbreak: an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol. 2020;258:1049–1055. https://doi.org/10.1007/s00417-020-04641-8.
  • Peiris JSM, Yuen KY, Osterhaus ADME, Stöhr K. The severe acute respiratory syndrome. N Engl J Med. 2003;349(25):2431–2441. doi:10.1056/NEJMra032498.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.